Post Job

Kalytera Therapeutics overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
50
Founded In
Organization Type
Public
Social Media
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
Kalytera Therapeutics is a small pharmaceutical company based in California with only 50 employees and an annual revenue of $680,000.

For less than a Netflix subscription, get a new job.

Floating question marks illustration
-

Kalytera Therapeutics employee reviews

Be the first to review!

Do you work at Kalytera Therapeutics?

Help job seekers learn about working at Kalytera Therapeutics

On This Page

Be The First To Review Kalytera Therapeutics

Anonymously rate your employee experience

Your Opinion can Help Other Job Seekers

Do You Like Working At Kalytera Therapeutics?

The team at Kalytera Therapeutics

  • The key people at Kalytera Therapeutics is Robert Edward Farrell.
Key People
Robert Edward Farrell

Rate Kalytera Therapeutics' promotion and raise policies.

Zippia waving zebra

Do you work at Kalytera Therapeutics?

Does Kalytera Therapeutics actively promote diversity and inclusion?

Kalytera Therapeutics Financial Performance

6.7
Performance Score

Are You An Executive, HR Leader, Or Brand Manager At Kalytera Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Kalytera Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Kalytera Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Kalytera Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Kalytera Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Kalytera Therapeutics. The data presented on this page does not represent the view of Kalytera Therapeutics and its employees or that of Zippia.

Kalytera Therapeutics may also be known as or be related to Kalytera Therapeutics and Kalytera Therapeutics, Inc.